The emerging approach of the medication represents a major advance in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and the GIP hormone – leading to https://tirzepatidepeptide533183.ltfblog.com/40469001/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment